Acer Therapeutics Inc. (ACER) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-03-30
4:20 pm
Sale
2023-03-2413DAcer Therapeutics Inc.
ACER
TVM Life Science Ventures VI LP1,697,709
7.200%
-974,600decrease
(-36.47%)
Filing
2023-02-14
4:56 pm
Purchase
2022-12-3113GAcer Therapeutics Inc.
ACER
Nantahala Capital Management, LLC1,226,191
7.500%
324,901increase
(+36.05%)
Filing
History
2022-12-02
4:02 pm
Purchase
2022-11-2913DAcer Therapeutics Inc.
ACER
Schelling Chris2,858,995
16.000%
907,626increase
(+46.51%)
Filing
History
2022-02-14
08:00 am
Sale
2021-12-3113GAcer Therapeutics Inc.
ACER
Nantahala Capital Management, LLC901,290
6.300%
-88,465decrease
(-8.94%)
Filing
History
2021-02-12
3:24 pm
Sale
2020-12-3113GAcer Therapeutics Inc.
ACER
Nantahala Capital Management, LLC989,755
8.100%
-900decrease
(-0.09%)
Filing
History